| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperalgesia | 43 | 2023 | 530 | 6.050 |
Why?
|
| Morphine | 25 | 2022 | 655 | 5.220 |
Why?
|
| Neuralgia | 26 | 2023 | 600 | 4.820 |
Why?
|
| Spinal Cord | 35 | 2022 | 1817 | 4.380 |
Why?
|
| Pain | 46 | 2022 | 5066 | 3.650 |
Why?
|
| Analgesics, Opioid | 41 | 2021 | 3763 | 3.470 |
Why?
|
| Nephrotic Syndrome | 7 | 2023 | 391 | 3.370 |
Why?
|
| Pain Threshold | 23 | 2021 | 603 | 2.870 |
Why?
|
| Drug Tolerance | 21 | 2019 | 369 | 2.820 |
Why?
|
| Rats, Sprague-Dawley | 61 | 2023 | 8158 | 2.340 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 19 | 2017 | 893 | 2.050 |
Why?
|
| Receptors, Glucocorticoid | 9 | 2007 | 296 | 1.990 |
Why?
|
| Pain Measurement | 38 | 2021 | 3528 | 1.950 |
Why?
|
| Analgesics | 12 | 2021 | 1065 | 1.940 |
Why?
|
| Trigeminal Neuralgia | 4 | 2023 | 106 | 1.890 |
Why?
|
| Rats | 70 | 2023 | 23711 | 1.870 |
Why?
|
| Electroacupuncture | 3 | 2022 | 66 | 1.580 |
Why?
|
| Amino Acid Transport System X-AG | 7 | 2008 | 39 | 1.340 |
Why?
|
| Cullin Proteins | 8 | 2021 | 178 | 1.340 |
Why?
|
| Conditioning, Operant | 3 | 2019 | 308 | 1.230 |
Why?
|
| Peripheral Nervous System Diseases | 9 | 2010 | 708 | 1.210 |
Why?
|
| F-Box Proteins | 4 | 2017 | 202 | 1.200 |
Why?
|
| Sciatic Nerve | 9 | 2020 | 613 | 1.190 |
Why?
|
| Behavior, Animal | 19 | 2021 | 1866 | 1.190 |
Why?
|
| Trigeminal Ganglion | 2 | 2019 | 190 | 1.160 |
Why?
|
| Cyclohexanecarboxylic Acids | 3 | 2017 | 140 | 1.110 |
Why?
|
| Amines | 3 | 2017 | 281 | 1.050 |
Why?
|
| Nephritis | 3 | 2017 | 149 | 1.050 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2020 | 1132 | 1.030 |
Why?
|
| Animals | 130 | 2024 | 167963 | 1.000 |
Why?
|
| Ketamine | 5 | 2017 | 516 | 1.000 |
Why?
|
| Ubiquitin-Protein Ligases | 6 | 2017 | 1889 | 0.990 |
Why?
|
| Azoxymethane | 2 | 2024 | 35 | 0.990 |
Why?
|
| Dextromethorphan | 6 | 2010 | 37 | 0.940 |
Why?
|
| Acupuncture Therapy | 4 | 2019 | 480 | 0.940 |
Why?
|
| Anesthetics, Dissociative | 3 | 2017 | 80 | 0.910 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 2 | 2017 | 120 | 0.900 |
Why?
|
| Narcotics | 5 | 2009 | 336 | 0.900 |
Why?
|
| Potassium Channels | 2 | 2016 | 534 | 0.870 |
Why?
|
| Drugs, Chinese Herbal | 3 | 2021 | 151 | 0.860 |
Why?
|
| Posterior Horn Cells | 7 | 2010 | 90 | 0.830 |
Why?
|
| Up-Regulation | 16 | 2016 | 4122 | 0.800 |
Why?
|
| Nocturnal Enuresis | 1 | 2021 | 12 | 0.800 |
Why?
|
| Sciatic Neuropathy | 3 | 2007 | 75 | 0.790 |
Why?
|
| Midazolam | 3 | 2016 | 267 | 0.770 |
Why?
|
| Gitelman Syndrome | 1 | 2021 | 4 | 0.760 |
Why?
|
| Cystinosis | 1 | 2021 | 26 | 0.740 |
Why?
|
| Radiculopathy | 5 | 2018 | 200 | 0.730 |
Why?
|
| Male | 139 | 2024 | 359744 | 0.730 |
Why?
|
| Dent Disease | 1 | 2020 | 1 | 0.720 |
Why?
|
| Dependovirus | 2 | 2022 | 709 | 0.720 |
Why?
|
| Cecum | 1 | 2021 | 232 | 0.720 |
Why?
|
| Freund's Adjuvant | 7 | 2020 | 149 | 0.710 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2017 | 685 | 0.710 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2023 | 580 | 0.710 |
Why?
|
| Acute Kidney Injury | 4 | 2018 | 1941 | 0.690 |
Why?
|
| Disease Models, Animal | 26 | 2024 | 18137 | 0.680 |
Why?
|
| Functional Laterality | 5 | 2017 | 2253 | 0.670 |
Why?
|
| Pyroglyphidae | 1 | 2019 | 88 | 0.670 |
Why?
|
| Burns | 7 | 2022 | 1866 | 0.660 |
Why?
|
| Smoke | 1 | 2021 | 236 | 0.660 |
Why?
|
| Neuropeptides | 2 | 2016 | 943 | 0.660 |
Why?
|
| Hepatitis | 1 | 2021 | 230 | 0.660 |
Why?
|
| Podocytes | 2 | 2021 | 402 | 0.660 |
Why?
|
| Leptin | 3 | 2014 | 1591 | 0.660 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2024 | 812 | 0.650 |
Why?
|
| Carcinogens | 2 | 2021 | 449 | 0.650 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2020 | 297 | 0.610 |
Why?
|
| Excitatory Amino Acid Antagonists | 7 | 2017 | 448 | 0.610 |
Why?
|
| Bacteria | 5 | 2024 | 2199 | 0.600 |
Why?
|
| Drug Resistance | 4 | 2018 | 1617 | 0.600 |
Why?
|
| Neck Pain | 1 | 2019 | 186 | 0.600 |
Why?
|
| Sensation | 1 | 2019 | 331 | 0.590 |
Why?
|
| China | 8 | 2023 | 2339 | 0.590 |
Why?
|
| Nortriptyline | 1 | 2017 | 79 | 0.580 |
Why?
|
| Amygdala | 2 | 2016 | 1351 | 0.560 |
Why?
|
| NF-kappa B | 4 | 2022 | 2488 | 0.560 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2017 | 106 | 0.550 |
Why?
|
| Kidney Calculi | 1 | 2021 | 468 | 0.540 |
Why?
|
| Protein Kinase C | 8 | 2014 | 1199 | 0.540 |
Why?
|
| Dizocilpine Maleate | 7 | 2011 | 172 | 0.540 |
Why?
|
| Buprenorphine | 4 | 2020 | 654 | 0.530 |
Why?
|
| Down-Regulation | 8 | 2015 | 2913 | 0.530 |
Why?
|
| Dose-Response Relationship, Drug | 18 | 2017 | 10827 | 0.520 |
Why?
|
| Analgesia | 3 | 2020 | 459 | 0.520 |
Why?
|
| Humans | 148 | 2024 | 760621 | 0.520 |
Why?
|
| Arsenic | 2 | 2017 | 357 | 0.510 |
Why?
|
| Arsenicals | 3 | 2010 | 117 | 0.510 |
Why?
|
| Methylphenidate | 1 | 2020 | 488 | 0.510 |
Why?
|
| Ubiquitin | 3 | 2012 | 838 | 0.510 |
Why?
|
| Fusion Proteins, bcr-abl | 3 | 2017 | 431 | 0.500 |
Why?
|
| Receptors, Melatonin | 2 | 2012 | 31 | 0.500 |
Why?
|
| Opioid-Related Disorders | 7 | 2020 | 2138 | 0.500 |
Why?
|
| Arthritis, Experimental | 3 | 2016 | 291 | 0.500 |
Why?
|
| Sulfides | 3 | 2010 | 171 | 0.490 |
Why?
|
| Diclofenac | 1 | 2015 | 67 | 0.490 |
Why?
|
| Hot Temperature | 9 | 2015 | 1435 | 0.490 |
Why?
|
| Allergens | 2 | 2019 | 1402 | 0.490 |
Why?
|
| Ganglia, Spinal | 2 | 2008 | 523 | 0.480 |
Why?
|
| Receptor, Cannabinoid, CB1 | 4 | 2023 | 138 | 0.480 |
Why?
|
| Cytokines | 8 | 2022 | 7343 | 0.480 |
Why?
|
| Thalamus | 3 | 2016 | 1041 | 0.480 |
Why?
|
| Neurons | 10 | 2023 | 9426 | 0.480 |
Why?
|
| Norepinephrine | 1 | 2017 | 900 | 0.480 |
Why?
|
| Cytomegalovirus Infections | 1 | 2021 | 831 | 0.480 |
Why?
|
| Child | 29 | 2023 | 79806 | 0.480 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2005 | 483 | 0.480 |
Why?
|
| Mifepristone | 8 | 2007 | 150 | 0.480 |
Why?
|
| Mice | 48 | 2024 | 81208 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 23 | 2024 | 22023 | 0.470 |
Why?
|
| Hippocampus | 4 | 2018 | 3738 | 0.460 |
Why?
|
| Microglia | 4 | 2022 | 1351 | 0.460 |
Why?
|
| Favism | 1 | 2013 | 3 | 0.450 |
Why?
|
| Hyperkinesis | 1 | 2014 | 89 | 0.450 |
Why?
|
| Meningitis, Bacterial | 1 | 2016 | 221 | 0.450 |
Why?
|
| Glutamic Acid | 6 | 2016 | 1167 | 0.450 |
Why?
|
| Memory | 3 | 2020 | 2179 | 0.450 |
Why?
|
| Physical Stimulation | 7 | 2017 | 518 | 0.440 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2019 | 1810 | 0.440 |
Why?
|
| Creatinine | 2 | 2018 | 1903 | 0.440 |
Why?
|
| Early Diagnosis | 1 | 2018 | 1180 | 0.440 |
Why?
|
| Injections, Spinal | 9 | 2016 | 316 | 0.440 |
Why?
|
| Blotting, Western | 11 | 2016 | 5039 | 0.430 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2017 | 1313 | 0.430 |
Why?
|
| Proteinuria | 2 | 2015 | 594 | 0.430 |
Why?
|
| Sciatica | 3 | 2021 | 97 | 0.430 |
Why?
|
| Melatonin | 2 | 2009 | 668 | 0.430 |
Why?
|
| Cell Cycle Proteins | 4 | 2024 | 3446 | 0.430 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 2012 | 18 | 0.430 |
Why?
|
| Neurogenesis | 2 | 2016 | 856 | 0.430 |
Why?
|
| Chronic Disease | 11 | 2016 | 9287 | 0.420 |
Why?
|
| Apoptosis | 9 | 2017 | 9501 | 0.420 |
Why?
|
| Drug Therapy, Combination | 7 | 2020 | 6498 | 0.420 |
Why?
|
| Bee Venoms | 1 | 2012 | 22 | 0.420 |
Why?
|
| Calcium Channels | 1 | 2016 | 619 | 0.420 |
Why?
|
| Microtubules | 1 | 2018 | 1072 | 0.410 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 579 | 0.410 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 3 | 2008 | 32 | 0.400 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2016 | 547 | 0.400 |
Why?
|
| Temporomandibular Joint Disorders | 2 | 2012 | 220 | 0.400 |
Why?
|
| Hematuria | 1 | 2013 | 233 | 0.390 |
Why?
|
| Naloxone | 2 | 2014 | 369 | 0.390 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2012 | 117 | 0.390 |
Why?
|
| Methadone | 2 | 2015 | 320 | 0.380 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2011 | 143 | 0.370 |
Why?
|
| Nerve Degeneration | 2 | 2005 | 748 | 0.360 |
Why?
|
| Triamcinolone | 2 | 2008 | 68 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2024 | 17790 | 0.360 |
Why?
|
| Geriatrics | 1 | 2015 | 387 | 0.360 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2012 | 818 | 0.360 |
Why?
|
| Formaldehyde | 2 | 2010 | 358 | 0.360 |
Why?
|
| Air Pollutants | 3 | 2019 | 2844 | 0.360 |
Why?
|
| N-Methylaspartate | 1 | 2011 | 231 | 0.360 |
Why?
|
| Hypersensitivity | 1 | 2019 | 1155 | 0.360 |
Why?
|
| Neural Stem Cells | 2 | 2015 | 884 | 0.360 |
Why?
|
| Aging | 5 | 2024 | 8651 | 0.350 |
Why?
|
| Somatosensory Cortex | 3 | 2024 | 511 | 0.350 |
Why?
|
| Mice, Knockout | 13 | 2020 | 14372 | 0.350 |
Why?
|
| Inflammation Mediators | 4 | 2021 | 1881 | 0.350 |
Why?
|
| Calcium Channels, N-Type | 1 | 2010 | 43 | 0.350 |
Why?
|
| Pain, Postoperative | 4 | 2020 | 1721 | 0.340 |
Why?
|
| Asymptomatic Diseases | 1 | 2013 | 587 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2024 | 8515 | 0.340 |
Why?
|
| Receptors, Notch | 1 | 2014 | 743 | 0.340 |
Why?
|
| Pain, Intractable | 1 | 2010 | 132 | 0.330 |
Why?
|
| Nerve Compression Syndromes | 2 | 2008 | 160 | 0.330 |
Why?
|
| Female | 71 | 2024 | 391270 | 0.330 |
Why?
|
| Vesicular Glutamate Transport Proteins | 1 | 2008 | 4 | 0.330 |
Why?
|
| Insulin-Secreting Cells | 1 | 2016 | 907 | 0.320 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 1869 | 0.320 |
Why?
|
| bcl-2-Associated X Protein | 3 | 2005 | 282 | 0.320 |
Why?
|
| Learning | 3 | 2018 | 1739 | 0.320 |
Why?
|
| Papilloma | 2 | 2012 | 141 | 0.320 |
Why?
|
| Minocycline | 1 | 2010 | 168 | 0.320 |
Why?
|
| Inflammation | 9 | 2023 | 10756 | 0.320 |
Why?
|
| Receptors, Cannabinoid | 2 | 2005 | 43 | 0.320 |
Why?
|
| Antibodies | 3 | 2015 | 2421 | 0.310 |
Why?
|
| Perception | 1 | 2015 | 1195 | 0.310 |
Why?
|
| Ion Channels | 1 | 2013 | 1043 | 0.310 |
Why?
|
| Heroin Dependence | 1 | 2009 | 172 | 0.310 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 10181 | 0.310 |
Why?
|
| Constriction | 4 | 2016 | 172 | 0.310 |
Why?
|
| Time Factors | 18 | 2017 | 40165 | 0.310 |
Why?
|
| Astrocytes | 2 | 2014 | 1338 | 0.310 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2012 | 1115 | 0.300 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2016 | 687 | 0.300 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2013 | 1135 | 0.300 |
Why?
|
| Signal Transduction | 15 | 2020 | 23376 | 0.300 |
Why?
|
| Protease La | 1 | 2007 | 4 | 0.300 |
Why?
|
| Organ Transplantation | 1 | 2018 | 1150 | 0.300 |
Why?
|
| Cell Differentiation | 3 | 2015 | 11481 | 0.290 |
Why?
|
| Hindlimb | 2 | 2010 | 510 | 0.290 |
Why?
|
| Immunosuppressive Agents | 2 | 2018 | 4166 | 0.290 |
Why?
|
| Receptors, GABA-A | 2 | 2009 | 621 | 0.290 |
Why?
|
| Depressive Disorder | 2 | 2012 | 3726 | 0.290 |
Why?
|
| Alternative Splicing | 1 | 2012 | 1091 | 0.290 |
Why?
|
| Reward | 1 | 2014 | 963 | 0.290 |
Why?
|
| Low Back Pain | 3 | 2017 | 979 | 0.290 |
Why?
|
| Disinfectants | 1 | 2008 | 130 | 0.290 |
Why?
|
| Temporomandibular Joint | 1 | 2008 | 196 | 0.280 |
Why?
|
| Ligation | 5 | 2011 | 448 | 0.280 |
Why?
|
| Kidney Diseases | 1 | 2018 | 2093 | 0.280 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2007 | 41 | 0.280 |
Why?
|
| Child, Preschool | 13 | 2019 | 42063 | 0.280 |
Why?
|
| Cell Proliferation | 11 | 2024 | 10446 | 0.280 |
Why?
|
| Lung Neoplasms | 9 | 2020 | 13262 | 0.280 |
Why?
|
| Attitude of Health Personnel | 2 | 2011 | 3865 | 0.270 |
Why?
|
| Lidocaine | 4 | 2013 | 538 | 0.270 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 694 | 0.270 |
Why?
|
| Analysis of Variance | 6 | 2012 | 6238 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4353 | 0.270 |
Why?
|
| Glucocorticoids | 4 | 2013 | 2145 | 0.270 |
Why?
|
| bcl-X Protein | 2 | 2005 | 413 | 0.270 |
Why?
|
| Epithelial-Mesenchymal Transition | 4 | 2024 | 730 | 0.260 |
Why?
|
| Sensory Receptor Cells | 1 | 2011 | 509 | 0.260 |
Why?
|
| Rats, Inbred WKY | 3 | 2012 | 151 | 0.260 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 1178 | 0.260 |
Why?
|
| Patch-Clamp Techniques | 3 | 2016 | 932 | 0.260 |
Why?
|
| Erythrocyte Indices | 2 | 2017 | 145 | 0.250 |
Why?
|
| Phantom Limb | 1 | 2007 | 96 | 0.250 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4550 | 0.250 |
Why?
|
| Arachidonic Acid | 1 | 2007 | 433 | 0.250 |
Why?
|
| Cognition Disorders | 3 | 2014 | 3976 | 0.250 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 2105 | 0.250 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 2282 | 0.250 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 323 | 0.250 |
Why?
|
| RNA, Messenger | 7 | 2016 | 12766 | 0.250 |
Why?
|
| Hemostatics | 1 | 2008 | 243 | 0.240 |
Why?
|
| Nerve Block | 2 | 2020 | 688 | 0.240 |
Why?
|
| Sepsis | 1 | 2019 | 2592 | 0.240 |
Why?
|
| Interleukin-6 | 5 | 2016 | 3215 | 0.240 |
Why?
|
| Transcription Factors | 7 | 2021 | 12103 | 0.240 |
Why?
|
| Graft Rejection | 1 | 2018 | 4426 | 0.240 |
Why?
|
| Models, Animal | 2 | 2014 | 2117 | 0.230 |
Why?
|
| Neuronal Plasticity | 3 | 2016 | 1430 | 0.230 |
Why?
|
| Risk Assessment | 5 | 2018 | 24123 | 0.230 |
Why?
|
| Drug Administration Schedule | 7 | 2019 | 4899 | 0.230 |
Why?
|
| Cyclic AMP | 2 | 2005 | 1456 | 0.230 |
Why?
|
| Immunoglobulin E | 3 | 2019 | 1484 | 0.230 |
Why?
|
| Whole-Body Irradiation | 1 | 2004 | 433 | 0.220 |
Why?
|
| Peripheral Nerves | 2 | 2008 | 475 | 0.220 |
Why?
|
| Receptors, Drug | 1 | 2003 | 157 | 0.220 |
Why?
|
| Labetalol | 1 | 2003 | 29 | 0.220 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 934 | 0.220 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2007 | 622 | 0.220 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2014 | 3604 | 0.210 |
Why?
|
| Random Allocation | 3 | 2017 | 2394 | 0.210 |
Why?
|
| Middle Aged | 36 | 2021 | 220352 | 0.210 |
Why?
|
| Vinculin | 1 | 2022 | 59 | 0.210 |
Why?
|
| Gyrus Cinguli | 2 | 2015 | 1114 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2024 | 15789 | 0.210 |
Why?
|
| Hyperesthesia | 1 | 2002 | 23 | 0.210 |
Why?
|
| Endocannabinoids | 1 | 2023 | 111 | 0.210 |
Why?
|
| Cerebral Cortex | 6 | 2023 | 5761 | 0.210 |
Why?
|
| Substance Abuse Detection | 2 | 2016 | 301 | 0.210 |
Why?
|
| Naphthalenes | 1 | 2003 | 198 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2016 | 2919 | 0.210 |
Why?
|
| Cell Line, Tumor | 19 | 2024 | 16939 | 0.200 |
Why?
|
| Stomach Neoplasms | 2 | 2024 | 1423 | 0.200 |
Why?
|
| Treatment Outcome | 18 | 2021 | 65017 | 0.200 |
Why?
|
| ROC Curve | 4 | 2017 | 3568 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 459 | 0.200 |
Why?
|
| Genotype | 4 | 2022 | 12960 | 0.200 |
Why?
|
| RNA Interference | 4 | 2015 | 2846 | 0.200 |
Why?
|
| Adult | 33 | 2021 | 219994 | 0.200 |
Why?
|
| Th1 Cells | 3 | 2021 | 1032 | 0.200 |
Why?
|
| Adenocarcinoma | 2 | 2017 | 6315 | 0.200 |
Why?
|
| Hormone Antagonists | 3 | 2007 | 108 | 0.200 |
Why?
|
| Factor IX | 1 | 2021 | 77 | 0.200 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2023 | 234 | 0.200 |
Why?
|
| Genes, ras | 1 | 2004 | 655 | 0.190 |
Why?
|
| Particulate Matter | 3 | 2019 | 2559 | 0.190 |
Why?
|
| Infant | 10 | 2020 | 36060 | 0.190 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2003 | 121 | 0.190 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 3 | 2012 | 58 | 0.190 |
Why?
|
| Fibromyalgia | 1 | 2006 | 401 | 0.190 |
Why?
|
| Species Specificity | 2 | 2021 | 2418 | 0.190 |
Why?
|
| Lumbar Vertebrae | 4 | 2019 | 1868 | 0.190 |
Why?
|
| Benzylidene Compounds | 1 | 2021 | 25 | 0.190 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2023 | 348 | 0.190 |
Why?
|
| Receptors, Leptin | 3 | 2015 | 350 | 0.180 |
Why?
|
| Pneumonia, Mycoplasma | 2 | 2018 | 50 | 0.180 |
Why?
|
| Prognosis | 10 | 2024 | 29658 | 0.180 |
Why?
|
| Anxiety | 2 | 2023 | 4538 | 0.180 |
Why?
|
| Lymphocyte Activation | 2 | 2019 | 5496 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1407 | 0.180 |
Why?
|
| Data Collection | 1 | 2010 | 3315 | 0.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2014 | 3986 | 0.180 |
Why?
|
| Morpholines | 1 | 2003 | 583 | 0.180 |
Why?
|
| Feces | 3 | 2023 | 1455 | 0.170 |
Why?
|
| Prospective Studies | 12 | 2023 | 54303 | 0.170 |
Why?
|
| Injections, Intravenous | 3 | 2008 | 1385 | 0.170 |
Why?
|
| Brain | 3 | 2020 | 26951 | 0.170 |
Why?
|
| Lymphocytes | 2 | 2005 | 2611 | 0.170 |
Why?
|
| Animals, Newborn | 3 | 2016 | 2672 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2015 | 11903 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 2802 | 0.170 |
Why?
|
| Germ-Free Life | 1 | 2020 | 187 | 0.170 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9585 | 0.170 |
Why?
|
| Chemistry, Pharmaceutical | 2 | 2015 | 276 | 0.170 |
Why?
|
| Ice | 1 | 2020 | 102 | 0.170 |
Why?
|
| Cryotherapy | 1 | 2020 | 161 | 0.170 |
Why?
|
| Trace Elements | 1 | 2021 | 196 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 478 | 0.170 |
Why?
|
| Lactates | 1 | 2020 | 404 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2012 | 4573 | 0.160 |
Why?
|
| Spermatogenesis | 1 | 2020 | 257 | 0.160 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 181 | 0.160 |
Why?
|
| Acetates | 1 | 2000 | 321 | 0.160 |
Why?
|
| Age Factors | 4 | 2021 | 18416 | 0.160 |
Why?
|
| Lactobacillus | 1 | 2020 | 204 | 0.160 |
Why?
|
| Nocodazole | 1 | 2018 | 95 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2024 | 1077 | 0.160 |
Why?
|
| Cisplatin | 2 | 2020 | 1644 | 0.160 |
Why?
|
| Leupeptins | 2 | 2008 | 113 | 0.160 |
Why?
|
| Enterocolitis | 1 | 2020 | 106 | 0.160 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 13630 | 0.160 |
Why?
|
| Genomic Instability | 2 | 2021 | 704 | 0.160 |
Why?
|
| Drug Interactions | 3 | 2011 | 1428 | 0.160 |
Why?
|
| Kidney Glomerulus | 1 | 2021 | 568 | 0.160 |
Why?
|
| Radiometry | 1 | 2024 | 813 | 0.160 |
Why?
|
| Transfection | 3 | 2022 | 5781 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4938 | 0.160 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2014 | 2471 | 0.150 |
Why?
|
| Pilot Projects | 5 | 2021 | 8555 | 0.150 |
Why?
|
| General Surgery | 1 | 2010 | 1678 | 0.150 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2018 | 43 | 0.150 |
Why?
|
| Intestinal Mucosa | 2 | 2020 | 3022 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2017 | 18957 | 0.150 |
Why?
|
| Chromosomes, Human, X | 1 | 2020 | 321 | 0.150 |
Why?
|
| Cadmium | 1 | 2019 | 215 | 0.150 |
Why?
|
| Hirschsprung Disease | 1 | 2020 | 163 | 0.150 |
Why?
|
| Tubulin Modulators | 1 | 2018 | 107 | 0.150 |
Why?
|
| Steroids | 1 | 2023 | 928 | 0.150 |
Why?
|
| Spinal Nerve Roots | 1 | 2018 | 121 | 0.150 |
Why?
|
| Gelsolin | 1 | 2018 | 189 | 0.150 |
Why?
|
| Alleles | 3 | 2021 | 6898 | 0.150 |
Why?
|
| HeLa Cells | 2 | 2017 | 3105 | 0.150 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2016 | 550 | 0.150 |
Why?
|
| Pyrimidines | 3 | 2016 | 3016 | 0.150 |
Why?
|
| Aged | 20 | 2021 | 169152 | 0.150 |
Why?
|
| Nuclear Proteins | 3 | 2021 | 5791 | 0.150 |
Why?
|
| Specialization | 1 | 2002 | 778 | 0.140 |
Why?
|
| Grooming | 1 | 2017 | 38 | 0.140 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2003 | 1259 | 0.140 |
Why?
|
| Diskectomy | 1 | 2019 | 209 | 0.140 |
Why?
|
| Cystatin C | 1 | 2018 | 270 | 0.140 |
Why?
|
| Mesothelioma | 2 | 2015 | 807 | 0.140 |
Why?
|
| Sex Factors | 3 | 2018 | 10547 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2019 | 780 | 0.140 |
Why?
|
| Skin Neoplasms | 4 | 2012 | 5799 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2021 | 755 | 0.140 |
Why?
|
| Ferrosoferric Oxide | 1 | 2018 | 348 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 2016 | 2440 | 0.140 |
Why?
|
| Mercury | 1 | 2019 | 290 | 0.140 |
Why?
|
| Long-Term Potentiation | 1 | 2018 | 293 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 2895 | 0.140 |
Why?
|
| Testis | 1 | 2020 | 794 | 0.140 |
Why?
|
| Drug Prescriptions | 2 | 2019 | 1673 | 0.140 |
Why?
|
| Rats, Wistar | 2 | 2012 | 1850 | 0.130 |
Why?
|
| Immunohistochemistry | 8 | 2017 | 11071 | 0.130 |
Why?
|
| Dopamine | 1 | 2023 | 1595 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 3 | 2016 | 1484 | 0.130 |
Why?
|
| Plasma Exchange | 1 | 2017 | 158 | 0.130 |
Why?
|
| Genetic Testing | 2 | 2020 | 3531 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2019 | 323 | 0.130 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 1006 | 0.130 |
Why?
|
| Critical Illness | 2 | 2019 | 2709 | 0.130 |
Why?
|
| Interneurons | 2 | 2023 | 591 | 0.130 |
Why?
|
| Sensory Thresholds | 1 | 2017 | 377 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1617 | 0.130 |
Why?
|
| Mutation | 7 | 2021 | 29932 | 0.130 |
Why?
|
| Neuroglia | 3 | 2014 | 944 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2009 | 6414 | 0.130 |
Why?
|
| Tachykinins | 1 | 2016 | 77 | 0.130 |
Why?
|
| Encephalitis, Viral | 1 | 2016 | 59 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 681 | 0.130 |
Why?
|
| Hemoglobinuria | 1 | 2015 | 13 | 0.130 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 15840 | 0.130 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 410 | 0.130 |
Why?
|
| Health Care Surveys | 2 | 2014 | 2435 | 0.130 |
Why?
|
| Retinal Vasculitis | 1 | 2016 | 46 | 0.130 |
Why?
|
| Incidence | 4 | 2018 | 21392 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 2 | 2016 | 1234 | 0.130 |
Why?
|
| STAT3 Transcription Factor | 2 | 2011 | 877 | 0.130 |
Why?
|
| Gamma Rays | 3 | 2012 | 317 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 7475 | 0.130 |
Why?
|
| Neoplasms | 3 | 2017 | 22072 | 0.130 |
Why?
|
| HCT116 Cells | 2 | 2017 | 402 | 0.130 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2016 | 167 | 0.130 |
Why?
|
| Rotavirus Infections | 1 | 2016 | 85 | 0.130 |
Why?
|
| Dyskeratosis Congenita | 1 | 2016 | 73 | 0.130 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 95 | 0.130 |
Why?
|
| Albuminuria | 1 | 2019 | 659 | 0.120 |
Why?
|
| Methylprednisolone | 2 | 2016 | 384 | 0.120 |
Why?
|
| Rotavirus | 1 | 2016 | 110 | 0.120 |
Why?
|
| Lymphoma | 2 | 2016 | 1898 | 0.120 |
Why?
|
| Resilience, Psychological | 1 | 2023 | 768 | 0.120 |
Why?
|
| Alendronate | 1 | 2016 | 173 | 0.120 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 2 | 2005 | 58 | 0.120 |
Why?
|
| Purkinje Cells | 1 | 2016 | 226 | 0.120 |
Why?
|
| Disease Progression | 4 | 2020 | 13502 | 0.120 |
Why?
|
| Biomedical Research | 2 | 2013 | 3426 | 0.120 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2015 | 198 | 0.120 |
Why?
|
| Injections, Epidural | 3 | 2017 | 200 | 0.120 |
Why?
|
| beta-Endorphin | 1 | 2014 | 43 | 0.120 |
Why?
|
| Morphine Dependence | 3 | 2002 | 26 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1246 | 0.120 |
Why?
|
| Hepatocytes | 1 | 2021 | 1229 | 0.120 |
Why?
|
| Glutamate Plasma Membrane Transport Proteins | 2 | 2004 | 11 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 2448 | 0.120 |
Why?
|
| Growth Hormone | 1 | 2016 | 568 | 0.120 |
Why?
|
| Neoplasm Proteins | 4 | 2016 | 3610 | 0.110 |
Why?
|
| Burnout, Professional | 1 | 2023 | 702 | 0.110 |
Why?
|
| Precancerous Conditions | 1 | 2021 | 977 | 0.110 |
Why?
|
| Medicine | 1 | 2002 | 943 | 0.110 |
Why?
|
| Phenotype | 3 | 2017 | 16546 | 0.110 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 12965 | 0.110 |
Why?
|
| Research | 1 | 2002 | 1974 | 0.110 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3465 | 0.110 |
Why?
|
| Glycoproteins | 1 | 2021 | 2208 | 0.110 |
Why?
|
| Casein Kinase II | 2 | 2012 | 122 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2536 | 0.110 |
Why?
|
| Endothelin-1 | 1 | 2015 | 302 | 0.110 |
Why?
|
| Dexamethasone | 3 | 2005 | 1927 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 474 | 0.110 |
Why?
|
| Pyramidal Cells | 1 | 2016 | 369 | 0.110 |
Why?
|
| Drug Delivery Systems | 1 | 2005 | 2221 | 0.110 |
Why?
|
| Lead | 1 | 2019 | 880 | 0.110 |
Why?
|
| Cycloheximide | 1 | 2013 | 343 | 0.110 |
Why?
|
| Administration, Topical | 1 | 2015 | 697 | 0.110 |
Why?
|
| NIH 3T3 Cells | 2 | 2012 | 670 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 4357 | 0.110 |
Why?
|
| Gene Components | 1 | 2012 | 27 | 0.110 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 590 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2012 | 410 | 0.110 |
Why?
|
| Metabolomics | 2 | 2020 | 1628 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2016 | 698 | 0.110 |
Why?
|
| Keratin-14 | 1 | 2012 | 56 | 0.110 |
Why?
|
| Pain Perception | 1 | 2014 | 196 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 2016 | 377 | 0.110 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 2 | 2004 | 89 | 0.110 |
Why?
|
| Adolescent | 8 | 2017 | 87810 | 0.110 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 4291 | 0.110 |
Why?
|
| Pyelonephritis | 1 | 2012 | 75 | 0.110 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 273 | 0.110 |
Why?
|
| Riluzole | 2 | 2003 | 58 | 0.100 |
Why?
|
| Protein Kinases | 2 | 2018 | 1612 | 0.100 |
Why?
|
| Drug Combinations | 3 | 2016 | 2025 | 0.100 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 15289 | 0.100 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2005 | 459 | 0.100 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2101 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 2015 | 695 | 0.100 |
Why?
|
| Depression | 1 | 2012 | 8044 | 0.100 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2012 | 63 | 0.100 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9411 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 2058 | 0.100 |
Why?
|
| Biopsy | 2 | 2015 | 6771 | 0.100 |
Why?
|
| Breast Neoplasms | 6 | 2024 | 21025 | 0.100 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2012 | 82 | 0.100 |
Why?
|
| Anesthetics, Local | 3 | 2013 | 1001 | 0.100 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 2234 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2015 | 782 | 0.100 |
Why?
|
| Anesthetics, Combined | 1 | 2011 | 43 | 0.100 |
Why?
|
| Leukocyte Count | 1 | 2016 | 1600 | 0.100 |
Why?
|
| Intestines | 1 | 2021 | 1907 | 0.100 |
Why?
|
| Caspase 3 | 2 | 2005 | 731 | 0.100 |
Why?
|
| Receptor, Insulin | 1 | 2015 | 836 | 0.100 |
Why?
|
| Constriction, Pathologic | 1 | 2015 | 1098 | 0.100 |
Why?
|
| Administration, Oral | 3 | 2006 | 4035 | 0.100 |
Why?
|
| Acyltransferases | 1 | 2013 | 305 | 0.100 |
Why?
|
| Deoxyglucose | 1 | 1992 | 333 | 0.100 |
Why?
|
| Germ Cells | 1 | 2015 | 635 | 0.100 |
Why?
|
| Rest | 1 | 2016 | 914 | 0.100 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2016 | 364 | 0.100 |
Why?
|
| Lectins | 1 | 2013 | 484 | 0.100 |
Why?
|
| Immunoglobulins | 1 | 2014 | 859 | 0.100 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2015 | 599 | 0.100 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.100 |
Why?
|
| Diabetes, Gestational | 1 | 2021 | 1242 | 0.090 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1296 | 0.090 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 1753 | 0.090 |
Why?
|
| Caspases | 2 | 2005 | 878 | 0.090 |
Why?
|
| Symporters | 2 | 2004 | 361 | 0.090 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2013 | 314 | 0.090 |
Why?
|
| Luciferases | 1 | 2012 | 716 | 0.090 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2012 | 369 | 0.090 |
Why?
|
| Opiate Substitution Treatment | 1 | 2015 | 436 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 678 | 0.090 |
Why?
|
| Paclitaxel | 1 | 2018 | 1736 | 0.090 |
Why?
|
| Medicine, Traditional | 1 | 2011 | 87 | 0.090 |
Why?
|
| Delirium | 1 | 2022 | 1663 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2010 | 3804 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1175 | 0.090 |
Why?
|
| Synaptotagmin I | 1 | 2010 | 33 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2007 | 4371 | 0.090 |
Why?
|
| Ankle | 1 | 2013 | 350 | 0.090 |
Why?
|
| Touch | 1 | 2012 | 312 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 3616 | 0.090 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2020 | 5251 | 0.090 |
Why?
|
| Neural Inhibition | 1 | 2014 | 589 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 3696 | 0.090 |
Why?
|
| Candidiasis | 1 | 2012 | 363 | 0.090 |
Why?
|
| Pleural Neoplasms | 2 | 2015 | 609 | 0.090 |
Why?
|
| Flavonoids | 2 | 2003 | 445 | 0.090 |
Why?
|
| Temperature | 3 | 2016 | 2221 | 0.090 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1710 | 0.090 |
Why?
|
| Bartter Syndrome | 1 | 2009 | 23 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2019 | 1223 | 0.090 |
Why?
|
| Treatment Failure | 2 | 2008 | 2648 | 0.090 |
Why?
|
| Benzodiazepinones | 1 | 2009 | 50 | 0.080 |
Why?
|
| Neuropharmacology | 1 | 2009 | 20 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2019 | 1699 | 0.080 |
Why?
|
| Acupuncture | 1 | 2010 | 90 | 0.080 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2180 | 0.080 |
Why?
|
| Receptors, Chemokine | 1 | 2012 | 655 | 0.080 |
Why?
|
| Mice, Nude | 4 | 2020 | 3607 | 0.080 |
Why?
|
| Convulsants | 1 | 2009 | 70 | 0.080 |
Why?
|
| Nephrosis, Lipoid | 1 | 2009 | 45 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2018 | 7850 | 0.080 |
Why?
|
| Thiocarbamates | 1 | 2008 | 30 | 0.080 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 2061 | 0.080 |
Why?
|
| Spinal Fusion | 1 | 2019 | 1281 | 0.080 |
Why?
|
| Orthopedic Procedures | 1 | 2019 | 1263 | 0.080 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 802 | 0.080 |
Why?
|
| Enzyme Inhibitors | 3 | 2005 | 3726 | 0.080 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2014 | 975 | 0.080 |
Why?
|
| Vaccination | 1 | 2021 | 3361 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2981 | 0.080 |
Why?
|
| Action Potentials | 1 | 2016 | 1816 | 0.080 |
Why?
|
| K562 Cells | 1 | 2010 | 640 | 0.080 |
Why?
|
| Health Policy | 1 | 2021 | 2677 | 0.080 |
Why?
|
| Radiation Tolerance | 1 | 2011 | 480 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2016 | 1067 | 0.080 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 412 | 0.080 |
Why?
|
| Neoplasm Transplantation | 4 | 2015 | 2014 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 7408 | 0.080 |
Why?
|
| Pyridines | 1 | 2021 | 2879 | 0.080 |
Why?
|
| Recurrence | 1 | 2021 | 8482 | 0.080 |
Why?
|
| Loss of Heterozygosity | 2 | 2016 | 659 | 0.080 |
Why?
|
| Behavior, Addictive | 1 | 2014 | 462 | 0.080 |
Why?
|
| Retrospective Studies | 8 | 2019 | 80372 | 0.080 |
Why?
|
| Ubiquitination | 2 | 2010 | 1008 | 0.080 |
Why?
|
| Bone Density Conservation Agents | 1 | 2016 | 796 | 0.080 |
Why?
|
| Radiation, Ionizing | 2 | 2024 | 251 | 0.080 |
Why?
|
| Risk Factors | 6 | 2019 | 74359 | 0.080 |
Why?
|
| Torsades de Pointes | 1 | 2009 | 79 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2020 | 22053 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2017 | 1380 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2019 | 4000 | 0.080 |
Why?
|
| Logistic Models | 3 | 2019 | 13314 | 0.080 |
Why?
|
| Microfilament Proteins | 2 | 2016 | 1135 | 0.080 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2008 | 189 | 0.080 |
Why?
|
| Young Adult | 6 | 2018 | 58741 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 12293 | 0.070 |
Why?
|
| Tacrolimus | 1 | 2011 | 733 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2017 | 1894 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2010 | 796 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 3618 | 0.070 |
Why?
|
| Mitosis | 1 | 2013 | 1191 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 4902 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 1171 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2873 | 0.070 |
Why?
|
| Executive Function | 1 | 2016 | 1374 | 0.070 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2008 | 73 | 0.070 |
Why?
|
| Mitochondria | 2 | 2020 | 3600 | 0.070 |
Why?
|
| Membrane Potentials | 1 | 2011 | 1095 | 0.070 |
Why?
|
| Antifungal Agents | 1 | 2012 | 749 | 0.070 |
Why?
|
| Binding Sites | 2 | 2017 | 6048 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1493 | 0.070 |
Why?
|
| Radiation Dosage | 3 | 2024 | 1958 | 0.070 |
Why?
|
| Interleukin-4 | 2 | 2018 | 1130 | 0.070 |
Why?
|
| Renal Dialysis | 1 | 2017 | 1801 | 0.070 |
Why?
|
| Antigens, CD1 | 1 | 2010 | 439 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3075 | 0.070 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 12626 | 0.070 |
Why?
|
| Fetal Development | 1 | 2012 | 766 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2020 | 3392 | 0.070 |
Why?
|
| Gene Expression | 3 | 2018 | 7588 | 0.070 |
Why?
|
| Ultraviolet Rays | 2 | 2014 | 1078 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2017 | 4264 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2012 | 1039 | 0.070 |
Why?
|
| Proline | 1 | 2008 | 457 | 0.070 |
Why?
|
| Homeostasis | 2 | 2011 | 3306 | 0.070 |
Why?
|
| Electric Stimulation | 2 | 2011 | 1735 | 0.070 |
Why?
|
| Acetylcysteine | 1 | 2008 | 264 | 0.070 |
Why?
|
| Genetic Linkage | 1 | 2012 | 2381 | 0.070 |
Why?
|
| Prednisone | 1 | 2011 | 1565 | 0.070 |
Why?
|
| Chloroquine | 1 | 2008 | 277 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12159 | 0.070 |
Why?
|
| Exons | 1 | 2012 | 2388 | 0.070 |
Why?
|
| Survival Analysis | 2 | 2017 | 10182 | 0.070 |
Why?
|
| Thalidomide | 1 | 2012 | 884 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 361 | 0.070 |
Why?
|
| GABA Modulators | 1 | 2006 | 109 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2015 | 3839 | 0.070 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 329 | 0.070 |
Why?
|
| Environmental Exposure | 1 | 2021 | 4412 | 0.070 |
Why?
|
| Reaction Time | 2 | 2020 | 2075 | 0.070 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2008 | 251 | 0.070 |
Why?
|
| Piperidines | 1 | 2014 | 1650 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2011 | 5434 | 0.070 |
Why?
|
| Nociceptors | 3 | 2007 | 457 | 0.070 |
Why?
|
| Th2 Cells | 2 | 2018 | 1047 | 0.070 |
Why?
|
| Gene Dosage | 3 | 2016 | 1218 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2003 | 1613 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2017 | 8313 | 0.060 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2005 | 48 | 0.060 |
Why?
|
| Janus Kinase 2 | 1 | 2009 | 542 | 0.060 |
Why?
|
| Cell Survival | 3 | 2015 | 5797 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2016 | 3040 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 122 | 0.060 |
Why?
|
| Dideoxyadenosine | 1 | 2004 | 14 | 0.060 |
Why?
|
| Length of Stay | 1 | 2019 | 6479 | 0.060 |
Why?
|
| Nicotinic Acids | 1 | 2004 | 31 | 0.060 |
Why?
|
| Systems Biology | 1 | 2009 | 482 | 0.060 |
Why?
|
| Spleen | 2 | 2016 | 2298 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2012 | 4024 | 0.060 |
Why?
|
| Osteitis Deformans | 1 | 2005 | 54 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1652 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2011 | 1195 | 0.060 |
Why?
|
| Oncogenes | 1 | 2011 | 1220 | 0.060 |
Why?
|
| Cobalt Radioisotopes | 1 | 2004 | 75 | 0.060 |
Why?
|
| Hepatitis C | 1 | 2015 | 1579 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5253 | 0.060 |
Why?
|
| Contrast Media | 1 | 2018 | 5305 | 0.060 |
Why?
|
| Neurosciences | 1 | 2009 | 353 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2005 | 240 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 39261 | 0.060 |
Why?
|
| Drug Implants | 1 | 2005 | 230 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 3826 | 0.060 |
Why?
|
| Myelitis | 1 | 2005 | 49 | 0.060 |
Why?
|
| Protein Kinase C-delta | 1 | 2004 | 114 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2008 | 1446 | 0.060 |
Why?
|
| Neoplastic Stem Cells | 1 | 2012 | 1347 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 2414 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 1120 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 6853 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2014 | 1999 | 0.060 |
Why?
|
| Receptors, Opioid, mu | 1 | 2005 | 166 | 0.060 |
Why?
|
| Cell Count | 2 | 2012 | 1835 | 0.060 |
Why?
|
| Mice, Transgenic | 4 | 2021 | 9530 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4107 | 0.060 |
Why?
|
| Synapses | 1 | 2013 | 1757 | 0.060 |
Why?
|
| Drug Design | 1 | 2009 | 1061 | 0.060 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2024 | 160 | 0.060 |
Why?
|
| RNA, Small Interfering | 4 | 2016 | 3442 | 0.060 |
Why?
|
| Clinical Competence | 2 | 2022 | 4783 | 0.060 |
Why?
|
| Arm | 1 | 2007 | 583 | 0.060 |
Why?
|
| Lumbosacral Region | 2 | 2017 | 291 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2011 | 1501 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 3527 | 0.060 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2003 | 116 | 0.060 |
Why?
|
| Germ-Line Mutation | 1 | 2012 | 1841 | 0.060 |
Why?
|
| Indole Alkaloids | 1 | 2003 | 23 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2010 | 1355 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 961 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2015 | 3959 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 3 | 2020 | 6216 | 0.050 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 491 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 2825 | 0.050 |
Why?
|
| Thalamic Nuclei | 1 | 2023 | 111 | 0.050 |
Why?
|
| Isoquinolines | 1 | 2004 | 353 | 0.050 |
Why?
|
| Fourier Analysis | 1 | 2024 | 439 | 0.050 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2004 | 393 | 0.050 |
Why?
|
| Sulfonylurea Compounds | 1 | 2004 | 221 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2014 | 2781 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2009 | 998 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2016 | 358 | 0.050 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 2002 | 36 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2010 | 3969 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 58995 | 0.050 |
Why?
|
| Leukemia | 1 | 2011 | 1520 | 0.050 |
Why?
|
| Cholinergic Agonists | 1 | 2022 | 75 | 0.050 |
Why?
|
| Protein Binding | 2 | 2012 | 9335 | 0.050 |
Why?
|
| Air Pollution | 1 | 2016 | 2317 | 0.050 |
Why?
|
| Adrenalectomy | 1 | 2004 | 348 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2002 | 157 | 0.050 |
Why?
|
| Benzoxazines | 1 | 2003 | 309 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2010 | 3682 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 2049 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2015 | 12427 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2022 | 5870 | 0.050 |
Why?
|
| Leg | 1 | 2007 | 1090 | 0.050 |
Why?
|
| Drug Synergism | 3 | 2013 | 1754 | 0.050 |
Why?
|
| Rodentia | 1 | 2023 | 260 | 0.050 |
Why?
|
| Trigeminal Nerve | 1 | 2023 | 248 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2020 | 6544 | 0.050 |
Why?
|
| Glutamate Decarboxylase | 1 | 2002 | 239 | 0.050 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 2021 | 25 | 0.050 |
Why?
|
| Carbazoles | 1 | 2003 | 220 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 613 | 0.050 |
Why?
|
| Hemophilia B | 1 | 2021 | 84 | 0.050 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2021 | 74 | 0.050 |
Why?
|
| Cell Line | 2 | 2012 | 15620 | 0.050 |
Why?
|
| Prostatic Neoplasms | 2 | 2015 | 11345 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2004 | 1249 | 0.050 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2021 | 112 | 0.050 |
Why?
|
| Antioxidants | 1 | 2008 | 1667 | 0.050 |
Why?
|
| Mexiletine | 1 | 2000 | 31 | 0.050 |
Why?
|
| Time | 1 | 2002 | 545 | 0.050 |
Why?
|
| Cell Movement | 3 | 2020 | 5206 | 0.050 |
Why?
|
| Dendritic Spines | 1 | 2022 | 243 | 0.040 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2021 | 128 | 0.040 |
Why?
|
| CpG Islands | 1 | 2005 | 1221 | 0.040 |
Why?
|
| Computational Biology | 1 | 2012 | 3505 | 0.040 |
Why?
|
| Skin | 1 | 2014 | 4466 | 0.040 |
Why?
|
| Biological Transport | 2 | 2003 | 2086 | 0.040 |
Why?
|
| Spermatogonia | 1 | 2020 | 30 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 2003 | 552 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2020 | 1513 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2013 | 3832 | 0.040 |
Why?
|
| Spinal Diseases | 1 | 2005 | 559 | 0.040 |
Why?
|
| Narcotic Antagonists | 2 | 2002 | 583 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2005 | 3602 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2004 | 1247 | 0.040 |
Why?
|
| Homozygote | 1 | 2004 | 1788 | 0.040 |
Why?
|
| Antidepressive Agents | 1 | 2011 | 2890 | 0.040 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2003 | 700 | 0.040 |
Why?
|
| Sodium Channel Blockers | 1 | 2000 | 172 | 0.040 |
Why?
|
| Patient Selection | 1 | 2011 | 4283 | 0.040 |
Why?
|
| DNA Damage | 2 | 2021 | 2442 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2010 | 13451 | 0.040 |
Why?
|
| Sperm Motility | 1 | 2020 | 265 | 0.040 |
Why?
|
| Oxygen | 2 | 2016 | 4193 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 5508 | 0.040 |
Why?
|
| Nicotinic Agonists | 1 | 2021 | 265 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 3387 | 0.040 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2003 | 707 | 0.040 |
Why?
|
| Central Nervous System | 2 | 2015 | 1334 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2016 | 26181 | 0.040 |
Why?
|
| Piperazines | 1 | 2009 | 2525 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 17624 | 0.040 |
Why?
|
| Actins | 1 | 2005 | 2049 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 1690 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2011 | 1860 | 0.040 |
Why?
|
| Comorbidity | 1 | 2012 | 10551 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2003 | 1521 | 0.040 |
Why?
|
| Heterozygote | 1 | 2004 | 2798 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 41335 | 0.040 |
Why?
|
| Hair | 1 | 2021 | 497 | 0.040 |
Why?
|
| Transcription Factor CHOP | 1 | 2017 | 68 | 0.040 |
Why?
|
| United States | 3 | 2019 | 72461 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 2018 | 268 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15697 | 0.040 |
Why?
|
| Injections | 1 | 2020 | 830 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2018 | 246 | 0.040 |
Why?
|
| Metformin | 1 | 2004 | 912 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2010 | 3598 | 0.030 |
Why?
|
| Cognition | 1 | 2014 | 6957 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 5785 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2017 | 200 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2016 | 63 | 0.030 |
Why?
|
| Myelin Sheath | 1 | 2020 | 652 | 0.030 |
Why?
|
| Receptors, GABA | 1 | 2018 | 305 | 0.030 |
Why?
|
| DNA Methylation | 2 | 2013 | 4373 | 0.030 |
Why?
|
| Receptors, Amino Acid | 1 | 1995 | 30 | 0.030 |
Why?
|
| Rats, Zucker | 1 | 2015 | 132 | 0.030 |
Why?
|
| Cholecystokinin | 1 | 2016 | 117 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2015 | 127 | 0.030 |
Why?
|
| Optic Atrophy | 1 | 2016 | 78 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2004 | 3157 | 0.030 |
Why?
|
| Kinetics | 1 | 2003 | 6377 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.030 |
Why?
|
| Acyclovir | 1 | 2016 | 268 | 0.030 |
Why?
|
| G(M1) Ganglioside | 1 | 1995 | 87 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 465 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2022 | 1248 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2015 | 2934 | 0.030 |
Why?
|
| Sulfonamides | 1 | 2004 | 1977 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 1356 | 0.030 |
Why?
|
| Indoles | 1 | 2023 | 1829 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 8056 | 0.030 |
Why?
|
| Complement C4 | 1 | 2014 | 244 | 0.030 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 14495 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2094 | 0.030 |
Why?
|
| Histones | 2 | 2015 | 2583 | 0.030 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 232 | 0.030 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 228 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 397 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2016 | 494 | 0.030 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 399 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 1738 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 1993 | 0.030 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2016 | 305 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2012 | 5643 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2017 | 795 | 0.030 |
Why?
|
| Palliative Care | 1 | 2008 | 3607 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 2004 | 1647 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2013 | 112 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 582 | 0.030 |
Why?
|
| Walking | 1 | 2020 | 1189 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 2012 | 138 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2012 | 7593 | 0.030 |
Why?
|
| Genes, cdc | 1 | 2013 | 115 | 0.030 |
Why?
|
| Curare | 1 | 1992 | 9 | 0.030 |
Why?
|
| Social Support | 1 | 2023 | 2145 | 0.030 |
Why?
|
| Complement C3 | 1 | 2014 | 451 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2012 | 12 | 0.030 |
Why?
|
| Stroke | 1 | 2015 | 9962 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 978 | 0.030 |
Why?
|
| Amphotericin B | 1 | 2012 | 142 | 0.030 |
Why?
|
| Urinalysis | 1 | 2014 | 368 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2018 | 4169 | 0.030 |
Why?
|
| Social Behavior | 1 | 2019 | 1131 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1447 | 0.030 |
Why?
|
| Outpatients | 1 | 2020 | 1607 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2017 | 1516 | 0.030 |
Why?
|
| Pain Clinics | 1 | 2012 | 51 | 0.030 |
Why?
|
| Axons | 1 | 2020 | 1673 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 1697 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 25942 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 2209 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2021 | 2907 | 0.020 |
Why?
|
| Particle Size | 1 | 2016 | 1644 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 1725 | 0.020 |
Why?
|
| Colon | 1 | 2020 | 1788 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2012 | 231 | 0.020 |
Why?
|
| DNA Repair | 1 | 2021 | 2039 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1871 | 0.020 |
Why?
|
| Tubulin | 1 | 2015 | 692 | 0.020 |
Why?
|
| Magic | 1 | 2011 | 14 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2016 | 873 | 0.020 |
Why?
|
| Autoradiography | 1 | 1992 | 730 | 0.020 |
Why?
|
| Drosophila | 1 | 2019 | 1492 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2020 | 1355 | 0.020 |
Why?
|
| Gangliosides | 1 | 1992 | 131 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 680 | 0.020 |
Why?
|
| Urine | 1 | 2012 | 363 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2014 | 979 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2012 | 751 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1992 | 557 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 364 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 507 | 0.020 |
Why?
|
| Paralysis | 1 | 1992 | 251 | 0.020 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 503 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 1173 | 0.020 |
Why?
|
| Ureteral Obstruction | 1 | 2012 | 292 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2012 | 881 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2003 | 2477 | 0.020 |
Why?
|
| Nicotine | 1 | 2015 | 677 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 2016 | 1045 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2015 | 850 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 551 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2016 | 836 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2011 | 283 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4490 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 419 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 1763 | 0.020 |
Why?
|
| Candida albicans | 1 | 2012 | 374 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2012 | 749 | 0.020 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2011 | 277 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2138 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 1006 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2010 | 514 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2004 | 8035 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 2852 | 0.020 |
Why?
|
| Proteins | 1 | 2024 | 6029 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 563 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 441 | 0.020 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 623 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2013 | 663 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 368 | 0.020 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 1055 | 0.020 |
Why?
|
| Curriculum | 1 | 2022 | 3718 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2022 | 6218 | 0.020 |
Why?
|
| Wound Healing | 1 | 2020 | 2788 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2018 | 3380 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1992 | 2262 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 6538 | 0.020 |
Why?
|
| Japan | 1 | 2012 | 1369 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2012 | 769 | 0.020 |
Why?
|
| Cholesterol | 1 | 2017 | 2924 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 877 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2017 | 2415 | 0.020 |
Why?
|
| Sleep | 1 | 2023 | 4751 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3584 | 0.020 |
Why?
|
| Ubiquitins | 1 | 2009 | 370 | 0.020 |
Why?
|
| Aquaporins | 1 | 2008 | 174 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2011 | 691 | 0.020 |
Why?
|
| G1 Phase | 1 | 2008 | 403 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 734 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 1755 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1895 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 12531 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11152 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 36290 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2018 | 4219 | 0.020 |
Why?
|
| Fear | 1 | 2014 | 1462 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2009 | 646 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2019 | 3736 | 0.020 |
Why?
|
| Glucose | 1 | 2017 | 4351 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2018 | 3340 | 0.020 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2005 | 168 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9631 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 1728 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9716 | 0.020 |
Why?
|
| Breast | 1 | 2013 | 1963 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2010 | 2506 | 0.010 |
Why?
|
| Polysomnography | 1 | 2011 | 1825 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8552 | 0.010 |
Why?
|
| Longevity | 1 | 2011 | 1050 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 7021 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2016 | 5125 | 0.010 |
Why?
|
| Carcinoma, Ductal | 1 | 2003 | 97 | 0.010 |
Why?
|
| Benzamides | 1 | 2009 | 1369 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 13981 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2012 | 2092 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2016 | 2884 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2012 | 4090 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3800 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2005 | 1167 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6465 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2005 | 788 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2015 | 6381 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2003 | 848 | 0.010 |
Why?
|
| Kidney | 1 | 2016 | 7064 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7509 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 4925 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1612 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 1955 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3663 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1974 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2008 | 1596 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11712 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8950 | 0.010 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 3844 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9185 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2864 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4713 | 0.010 |
Why?
|
| Pregnancy | 1 | 2021 | 29749 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 9073 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 3242 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2016 | 5649 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2013 | 6551 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3775 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 9994 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 10344 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 9467 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 12808 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4407 | 0.010 |
Why?
|
| Cytosol | 1 | 1995 | 887 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1994 | 1265 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1994 | 708 | 0.010 |
Why?
|
| HIV Infections | 1 | 2015 | 17165 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 14660 | 0.000 |
Why?
|
| Motor Activity | 1 | 1996 | 2687 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 20080 | 0.000 |
Why?
|